Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

Conley RR, Tamminga CA, Kelly DL, Richardson CM. Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response. Biol Psychiatry. 1999;46(1):73-7. PubMed PMID: 10394475.

Pathways to aggression in schizophrenia affect results of treatment.

Volavka J, Citrome L. Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull. 2011;37(5):921-9. DOI: 10.1093/schbul/sbr041. PubMed PMID: 21562140; PubMed Central PMCID: PMC3160235.

The effects of clozapine on tardive dyskinesia.

Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane J. The effects of clozapine on tardive dyskinesia. Br J Psychiatry. 1991;158:503-10. PubMed PMID: 1675900.

Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region.

Weissman EM. Antipsychotic prescribing practices in the Veterans Healthcare Administration--New York metropolitan region. Schizophr Bull. 2002;28(1):31-42. PubMed PMID: 12047020.

Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia.

Mallinger JB, Fisher SG, Brown T, Lamberti JS. Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia. Psychiatr Serv. 2006;57(1):133-6. DOI: 10.1176/appi.ps.57.1.133. PubMed PMID: 16399976.

Racial disparity in the use of atypical antipsychotic medications among veterans.

Copeland LA, Zeber JE, Valenstein M, Blow FC. Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry. 2003;160(10):1817-22. DOI: 10.1176/appi.ajp.160.10.1817. PubMed PMID: 14514496.

Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

Kelly DL, Dixon LB, Kreyenbuhl JA, Medoff D, Lehman AF, Love RC, et al. Clozapine utilization and outcomes by race in a public mental health system: 1994-2000. J Clin Psychiatry. 2006;67(9):1404-11. PubMed PMID: 17017827.

Reason for clozapine cessation.

Pai NB, Vella SC. Reason for clozapine cessation. Acta Psychiatr Scand. 2012;125(1):39-44. DOI: 10.1111/j.1600-0447.2011.01776.x. PubMed PMID: 22017729.

Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia.

Combs DR, Advokat C. Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia. Schizophr Res. 2000;46(2-3):129-37. PubMed PMID: 11120425.

Effects of clozapine on smoking in chronic schizophrenic outpatients.

George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 1995;56(8):344-6. PubMed PMID: 7635849.